These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


714 related items for PubMed ID: 15971472

  • 1. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare.
    Nguyen WT, Stewart C, Fisher K, Tolley E, Lew DB, Self TH.
    Allergy Asthma Proc; 2005; 26(2):129-34. PubMed ID: 15971472
    [Abstract] [Full Text] [Related]

  • 2. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 3. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [Abstract] [Full Text] [Related]

  • 4. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR, Ringdal N, Backer V, Palmqvist M, Saarelainen S, Briggs M.
    Can Respir J; 1999 Jun; 6(1):45-51. PubMed ID: 10202220
    [Abstract] [Full Text] [Related]

  • 5. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 Jun; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 6. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
    Blais L, Beauchesne MF, Forget A.
    Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647
    [Abstract] [Full Text] [Related]

  • 7. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS, Custovic A, Lowe LA, Aldington S, Williams M, Beasley R, Woodcock A.
    Allergy Asthma Proc; 2010 Feb; 31(5):415-21. PubMed ID: 20929609
    [Abstract] [Full Text] [Related]

  • 8. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L, Forget A, Ramachandran S.
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [Abstract] [Full Text] [Related]

  • 9. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 10. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA, Lyseng-Williamson KA, Wiseman LR.
    Drugs; 2005 Apr; 65(12):1715-34. PubMed ID: 16060707
    [Abstract] [Full Text] [Related]

  • 11. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [Abstract] [Full Text] [Related]

  • 12. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
    Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI.
    Pediatr Pulmonol; 2000 Aug; 30(2):97-105. PubMed ID: 10922131
    [Abstract] [Full Text] [Related]

  • 14. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J, Hui RL, Spence MM.
    J Manag Care Pharm; 2007 Aug; 13(1):21-7. PubMed ID: 17269833
    [Abstract] [Full Text] [Related]

  • 15. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T.
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [Abstract] [Full Text] [Related]

  • 16. Dispensing of fluticasone propionate/salmeterol combination in the summer and asthma-related outcomes in the fall.
    Spahn J, Sheth K, Yeh WS, Stempel DA, Stanford RH.
    J Allergy Clin Immunol; 2009 Dec; 124(6):1197-203. PubMed ID: 19910037
    [Abstract] [Full Text] [Related]

  • 17. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
    Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.
    Curr Med Res Opin; 2009 Jan; 25(1):1-13. PubMed ID: 19210134
    [Abstract] [Full Text] [Related]

  • 18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
    Katial RK, Bernstein D, Prazma CM, Lincourt WR, Stempel DA.
    Allergy Asthma Proc; 2011 Aug; 32(2):127-36. PubMed ID: 21189151
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.